Page last updated: 2024-08-21

alpha-aminopyridine and Dermatitis, Atopic

alpha-aminopyridine has been researched along with Dermatitis, Atopic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Berk, D; Bhatia, N; Bissonnette, R; Draelos, Z; Droege, M; Eads, K; Elias, M; Ferris, L; Gooderham, M; Guenthner, S; Higham, R; Jones, T; Kempers, S; Kircik, L; Koppel, R; Lee, M; Merritt, C; Navale, L; Saint-Cyr Proulx, E; Welgus, H; Zirwas, M1
Chat, VS; Kearns, DG; Uppal, SK; Wu, JJ1
Savall, BM; Thurmond, RL; Tichenor, MS; Venable, JD1
Cheon, HG; Cho, YS; Heo, JY1
Burnet, M; Guse, JH; Gutke, HJ; Khobzaoui, M; Renukappa-Gutke, T1

Reviews

3 review(s) available for alpha-aminopyridine and Dermatitis, Atopic

ArticleYear
Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis.
    Journal of drugs in dermatology : JDD, 2020, 10-01, Volume: 19, Issue:10

    Topics: Administration, Cutaneous; Aminopyridines; Benzamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Dermatitis, Atopic; Dermatologic Agents; Humans; Nitriles; Pyrazoles; Pyrimidines; Resorcinols; Severity of Illness Index; Skin Cream; Stilbenes; Treatment Outcome

2020
Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators.
    Journal of medicinal chemistry, 2015, Sep-24, Volume: 58, Issue:18

    Topics: Aminopyridines; Animals; Arthritis, Rheumatoid; Asthma; Dermatitis, Atopic; Drug Partial Agonism; Histamine Agonists; Histamine Antagonists; Humans; Hypersensitivity; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Structure-Activity Relationship

2015
AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).
    Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:11

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Administration, Topical; Amides; Aminopyridines; Animals; Benzamides; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dermatitis, Atopic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Indoles; Inflammation; Lipopolysaccharides; Ovalbumin; Phosphodiesterase Inhibitors; Psoriasis; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Structure-Activity Relationship

2005

Trials

1 trial(s) available for alpha-aminopyridine and Dermatitis, Atopic

ArticleYear
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
    Journal of drugs in dermatology : JDD, 2023, Feb-01, Volume: 22, Issue:2

    Topics: Aminopyridines; Benzamides; Dermatitis, Atopic; Double-Blind Method; Emollients; Humans; Proof of Concept Study; Severity of Illness Index; Treatment Outcome

2023

Other Studies

1 other study(ies) available for alpha-aminopyridine and Dermatitis, Atopic

ArticleYear
Topical effects of roflumilast on 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
    Die Pharmazie, 2010, Volume: 65, Issue:12

    Topics: Aminopyridines; Animals; Benzamides; Body Weight; Cell Line; Cell Proliferation; Cyclic AMP; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Down-Regulation; Female; Humans; Immunoglobulin E; Interleukin-1alpha; Irritants; Local Lymph Node Assay; Lymph Nodes; Mice; Mice, Inbred BALB C; Phosphodiesterase 4 Inhibitors; Skin; Th1 Cells

2010